For decades, USP <88> Class VI testing has been a benchmark for biocompatibility in elastomers used in biopharmaceutical manufacturing. But, as Cory Perelman, Lead Instrumentation & Controls Engineer at Arcadis outlined in his presentation at the 2025 Mid-Atlantic Science & Technology Showcase, industry standards are evolving—and with growing concerns over animal testing and regulatory clarity, the shift away from USP <88> is gaining momentum. Read more
